Incorporating public and wider stakeholder views in the design of health state valuation studies in adults and young people : an undervalued resource?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Expert review of pharmacoeconomics & outcomes research - (2024) vom: 25. März, Seite 1-4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Powell, Philip A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Editorial |
|---|
| Anmerkungen: |
Date Revised 25.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1080/14737167.2024.2334349 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370072588 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370072588 | ||
| 003 | DE-627 | ||
| 005 | 20240325235517.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240323s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14737167.2024.2334349 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1347.xml |
| 035 | |a (DE-627)NLM370072588 | ||
| 035 | |a (NLM)38517687 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Powell, Philip A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Incorporating public and wider stakeholder views in the design of health state valuation studies in adults and young people |b an undervalued resource? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Health state valuation | |
| 650 | 4 | |a QALY | |
| 650 | 4 | |a health technology assessment | |
| 650 | 4 | |a patient and public involvement | |
| 650 | 4 | |a preferences | |
| 650 | 4 | |a qualitative research | |
| 650 | 4 | |a stakeholder engagement | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of pharmacoeconomics & outcomes research |d 2001 |g (2024) vom: 25. März, Seite 1-4 |w (DE-627)NLM187860815 |x 1744-8379 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:25 |g month:03 |g pages:1-4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14737167.2024.2334349 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 25 |c 03 |h 1-4 | ||